glp-1 brand name drugs Agonists: A Comprehensive Overview This gentle Considering GLP-1 drugs for weight

How are Wegovy and Saxenda different

As of February 2024, 15 GLP-1 medications had received FDA approval for blood sugar and weight control, with more in development

In a recent study by Shan et al

Because cancer takes time to develop and manifest clinically, and because the nature and timing of a potential association between GLP1 receptor agonists and thyroid cancer are not known, the definition allowed identification of thyroid cancer events while on treatment and after treatment had stopped

Empagliflozins ability to reduce blood sugar levels independently of insulin action makes it a valuable option for those with insulin resistance, a hallmark of type 2 diabetes

GLP-1 medications also carry an FDA black box warning for risk of thyroid C-cell tumors, and should not be used by patients with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2 (MEN2)